18 insiders have filed at PTCT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Klein Matthew B. | Chief Executive Officer | 396.9k | 0.481% | 19 sells $4.7M | |
| Schmertzler Michael | Director | 163.3k | 0.198% | 1 sells $42k | |
| Almstead Neil Gregory | Chief Technical Ops Officer | 114.9k | 0.139% | 59 sells $17.3M | |
| Boulding Mark Elliott | Exec. VP And CLO | 105.2k | 0.127% | 73 sells $17.3M | |
| Gravier Pierre | Chief Financial Officer | 87.3k | 0.106% | 1 buys $199k | 6 sells $691k |
| Golden Lee Scott | EVP & Chief Medical Officer | 79.9k | 0.097% | 14 sells $1.3M | |
| Pauwels Eric | Chief Business Officer | 77.1k | 0.093% | 46 sells $9.2M | |
| Utter Christine Marie | SVP, Chief Accounting Officer | 70.2k | 0.085% | 15 sells $1.7M | |
| Zeldis Jerome B | Director | 22.5k | 0.027% | 6 sells $2.0M | |
| Steele Glenn JR Md Phd | Director | 22.5k | 0.027% | 1 sells $916k | |
| Smith Mary L. | Director | 21.8k | 0.026% | ||
| Jacobson Allan Steven | Director | 21.5k | 0.026% | 14 sells $3.3M | |
| Young Alethia | Director | 21.1k | 0.026% | 2 sells $465k | |
| Southwell David P | Director | 20.9k | 0.025% | 1 sells $700k | |
| Reeve Emma | Director | 10.7k | 0.013% | 19 sells $5.2M | |
| Bell William F. JR. | Director | 10.3k | 0.013% | ||
| Okey Stephanie | Director | 8.0k | 0.01% | 4 sells $1.7M | |
| Chutter Jessica Caroline | Director | 7.3k | <0.01% |
Full register at boothcheck.com/insiders/PTCT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.